학술논문

Subcutaneous Epcoritamab in Combination with Rituximab plus Lenalidomide (R-2) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial
Document Type
ConferencePaper
Source
BLOOD. 140:1471-1473
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
0006-4971